Related Experiment Videos

[Status of cellular immunity in diabetic microangiopathy detected by skin biopsy]

Terapevticheskii Arkhiv
|January 1, 1986
PubMed

Insights

Diabetes mellitus significantly impairs cell-mediated immunity, decreasing key lymphocyte counts and altering migration patterns. These immune changes develop early and worsen with microangiopathy, regardless of diabetes severity.

Area of Science:

  • Immunology
  • Endocrinology
  • Pathology

Context:

  • Diabetes mellitus is a chronic metabolic disorder associated with immune dysregulation.
  • Cell-mediated immunity plays a crucial role in host defense and is potentially affected by diabetes.
  • Diabetic microangiopathy is a common complication affecting small blood vessels.

Purpose:

  • To investigate the impact of diabetes mellitus on cell-mediated immunity.
  • To determine the relationship between the duration of diabetes, its severity, and immune system alterations.
  • To assess the correlation between diabetic microangiopathy and changes in immune cell profiles.

Summary:

  • Patients with diabetes mellitus exhibited significantly reduced spontaneous leukocyte migration and lower absolute counts of T-, B-, and O-lymphocytes compared to healthy individuals.
  • A relative increase in D-lymphocytes was observed in diabetic patients.
  • These immune system disorders manifest within the first five years of diabetes and are independent of overall disease severity.
  • Immune dysregulation progresses with the development and severity of diabetic microangiopathy, as confirmed by skin biopsy analysis.

Impact:

  • Highlights early immune system dysfunction in diabetes mellitus.
  • Suggests immune changes are linked to microvascular complications rather than glycemic control alone.
  • Provides insights into the pathogenesis of diabetes-related immune alterations and complications.

Related Concept Videos